Today’s AI Top Pick: NCLH

9/14/2026 · Highly Shorted Oversold screen · a free sample of K3vl4r’s AI-curated picks.

AI-ranked from a screened shortlist, with entry strategy, targets, and risks.

View the live NCLH price forecast →

Today's pick · Highly Shorted OversoldNCLHBUY NOW8.0 / 109/14/2026

NCLH is the cleanest multi-timeframe setup in the pool and it's the ONLY candidate with all four timeframes (1h/4h/1d/1wk) available and all pointing up together. The forecast stack is coherent, not one-bar noise: 1h fc_mid 18.39% / fc_long 26.13%, 4h 36.02% / 24.10%, 1d 37.41% / 39.30%, and 1wk 35.38% / 44.53%. That's exactly the 'multi-timeframe agreement is gold' pattern the brief asks for, and Kronos bullish_prob is 1.0 with near_term_bullish 1.0. Entry location is favorable rather than chasing: pos_in_21bar_range_pct is 40.3% on 1h, 5.5% on 4h, 2.8% on 1d, and 0% on 1wk, with weekly drawdown of -30.8% from the 21-bar high. RSI is 28.33 and the stock just hit a 1-year low — classic oversold-bounce setup that the screen is explicitly built to catch. Unlike the deeper drawdowns in the pool, NCLH isn't broken tape — it's a mean-reversion candidate off a defined base. Fundamentally, NCLH is the strongest real business in the list without a landmine attached. TTM PE 9.37, fwdPe 8.74, profitMargin 7.49%, ROE 36.73%, salesYoY +6.21%, operMargin 15.81%, and analyst recom 2.45 with targetUpsidePct 33.8. Debt/eq of 6.21 is elevated (cruise-line normal) but earnings are real, unlike the mostly-negative-margin healthcare/spec names ranked around it. Fundamental_score 3.25 undersells it because the model doesn't reward the lack of a negative catalyst. Why today vs. waiting: headlines are benign (Zacks/Yahoo daily-move noise, not guidance cuts or downgrades). Compare that to KRMN (J Capital short-seller report 9/2 — direct landmine on the highest-scored name), XPOF (cut guidance 9/6), BCRX (RBC 'challenging near-term outlook' 9/10), TRIP ('waning bookings' 9/9), and WHR (dividend-cut watchlist 9/12). Waiting risks missing the reversion off the 1wk low with the tape and news lining up.

Entry zone
$14.40–$14.85 (scale in at current $14.69; add on any dip toward the 1wk low near $14.30)
Stop loss
$13.40 (roughly 9% below entry, under the 21-bar weekly low; a break here invalidates the bounce)
First target
$16.50 (aligns with 1h fc_mid ~18% and 4h fc_short 5.4% → next resistance shelf)
Longer target
$19.50–$20.50 (1d/1wk fc_mid/long 35–44% zone; also matches analyst targetUpside ~34%)
Risks
  • Debt/equity of 6.21 makes NCLH rate-sensitive; a hawkish surprise could re-break the tape
  • Short float 19.04% cuts both ways — can fuel a squeeze but also means a fresh negative headline gets amplified to the downside
  • Stock is at a 1-year low with -33.6% YTD and -44.99% 1yr; if $14.30 breaks, next support is materially lower
  • Consumer-cyclical/travel demand rollover risk — a soft booking print would invalidate the mean-reversion
  • 1h forecast is the weakest leg (fc_short only +2.5%), so upside is not immediate — expect chop before trend
Honorable mentions
RHStrong multi-tf alignment (1d fc_long 51.3%, 1wk fc_mid 104.3% / fc_long 105.4%), bullish_prob 1.0, peg 0.51, fwdPe 14.73, and a fresh positive catalyst in the RH Estates launch on the Q2 call. Held back only by 1wk pos_in_range of 13.5% (slightly extended vs. NCLH), lower targetUpside (19.9%), and margin-pressure commentary in the earnings recap.
ENOVFull 4h/1d/1wk stack all bullish (1wk fc_mid 69.7%, fc_long 132.0%), fwdPe 5.22, peg 0.75, recom 1.23, targetUpside 98.8%, and an insider buy (Engert +2,660 sh on 9/9). Docked one slot for negative profitMargin (-47.9%) and a 'fair value cut' analyst headline.
Full ranking (15)
#SymbolVerdictScoreRead
1NCLHBUY NOW8.0Only name with all 4 TFs aligned bullish, real earnings (PE 9.37, margin 7.49%), 1wk pos_in_range 0%, no negative catalyst.
2RHBUY NOW7.6Multi-tf bullish with monster 1wk fc_long 105.4%, peg 0.51, fresh RH Estates catalyst — cleanest 'growth-at-a-discount' name.
3ENOVBUY NOW7.2fwdPe 5.22, recom 1.23, insider buy, 1wk fc_long +132% and multi-tf agreement; margin negativity is the only knock.
4WHRBUY PULLBACK6.3All 4 TFs positive with 1wk fc_long +189%, but dividend-cut watchlist headline and Wells Fargo PT cut to $39 argue for a lower entry.
5BROSBUY PULLBACK6.0bullish_prob 1.0 and TD Cowen still Buy, but 1wk forecasts are weak (fc_mid +4.7%) and PT was just lowered to $59.
6TRIPWAIT5.4Big fc_long (1wk +113.5%) but PE 900 and 'waning bookings' Seeking Alpha piece undercuts the mean-reversion thesis.
7FIPWAIT5.2Strong 4h/1d forecasts but 1wk forecasts flatten (+3–17%), profitMargin -91.3%, and mixed StockStory coverage.
8HROWWAIT4.8Leerink Outperform PT $45 is nice, but 1wk fc_short/mid/long all NEGATIVE (-2.4/-24.4/-58.7%) — trend is deteriorating on the long TF.
9FLOWAIT4.5Huge 1wk fc_long +214% looks like an outlier; epsNextY -7.38 and dividend analysis pieces raise sustainability questions.
10BCRXWAIT4.2Best fund_score (4.75) but RBC 'challenging near-term outlook' on 9/10 and 5-day losing streak — landmine on the forecast.
11KRMNAVOID4.0Top raw score (13.75) is undercut by J Capital short-seller report 9/2 titled 'Anyone can pay $10 for a $5 bill' — don't pick fights with active short thesis.
12ASPIWAIT3.8Single-TF 4h fc_short +123% is an outlier; operMargin -312%, ps 16.45 — post Capital Markets Day pop, no multi-tf confirmation.
13JBIOAVOID2.51wk fc_short/mid/long all -74.3% — model is explicitly bearish on the only available timeframe.
14XPOFAVOID2.3Cut guidance 9/6 and swung to a loss; single-TF forecast is unreliable against fresh negative catalyst.
15AEMDAVOID2.0$2.45M market cap, instOwn 3.31%, perfYear -96.1%; forecasts are essentially untradeable numerically (1wk fc +12,312%).

Get AI top picks & forecasts on any stock

K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.

Create your free account →

Already a member? Sign in · Join our Discord

⚠️ This AI-generated analysis is for informational purposes only and is not financial advice. Forecasts and scores are model outputs that can be wrong; markets involve substantial risk of loss. Do your own research.